| 孔瑜,马秀梅,施丹莉,赵新鲜.肿瘤患者放射治疗期间营养支持情况调查[J].上海护理,2024,24(S1): |
| 肿瘤患者放射治疗期间营养支持情况调查 |
| Investigational study on nutritional support for patients with malignant tumors during radiotherapy |
| 投稿时间：2024-03-28 修订日期：2024-03-28 |
| DOI： |
| 中文关键词: 肿瘤 放射治疗 营养支持 |
| 英文关键词:Malignant tumors Radiotherapy Nutritional support |
| 基金项目: |
|
| 摘要点击次数: 1434 |
| 全文下载次数: 0 |
| 中文摘要: |
| 目的：这项前瞻性设计的观察性研究目的是调查肿瘤患者放射治疗期间的营养支持情况。方法：研究主要入组标准为：本科收治的病理确诊的5大恶性肿瘤(原发于鼻咽、食管、肺、宫颈、肠),接受4周以上放射治疗。入组患者在放疗前、放疗中及放疗结束时采用营养风险筛查量表NRS 2002进行营养风险评分,营养不良风险定义为总评分≥3分。详细记录患者放疗期间的营养支持情况。结果：2018年6月-2019年3月共有98例患者符合入组标准并愿意参加此项研究,4例患者退出研究,94例患者进入本项研究分析。84例患者(89.4%)联合化疗或/和靶向治疗。患者在放射治疗中的营养不良风险呈上升趋势,放疗前、中、后的发生率分别为39.4%、56.4%、64.9%。78例(83%)患者进行了营养支持治疗,主要采用肠内联合肠外营养的方式(52.6%),其次为肠外营养(37.2%),单纯肠内营养10.2%。鼻咽癌(95.4%)、食管癌(97.6%)和肺癌(90.0%)的营养支持率均明显高于宫颈癌(38.5%)和肠癌(37.5%),P＜0.05。结论：肿瘤患者营养风险发生率较高,在放射治疗期间曾上升趋势,不同解剖部位肿瘤的营养支持治疗率不同,营养支持治疗保证了患者放射治疗的顺利完成。 |
| 英文摘要: |
| Objective: The prospectively designed observational study was to investigate the nutritional support of cancer patients during radiotherapy. Method: Patients with pathologically confirmed malignant tumors (primarily located in the nasopharynx, esophagus, lung, cervix, and intestine) were enrolled. All patients must receive radiotherapy for more than 4 weeks. Nutritional Risk Screening Scale NRS 2002 was used for evaluating nutritional risk before, during and at the end of radiotherapy, and the risk of malnutrition was defined as the total score ≥ 3 points. The patient"s nutritional support were recorded carefully during radiotherapy in detail. Results: From June 2018 to March 2019, a total of 98 patients met the enrollment criteria and were willing to participate in the study, 4 patients withdrew from the study, and 94 patients entered the study analysis. 84 patients (89.4%) were treated with radiotherapy and chemotherapy or/and targeted therapy. The risk of malnutrition in patients was increasing during the treatment, and the incidence rates before, during and after radiotherapy are 39.4%, 56.4%, and 64.9%, respectively. Seventy-eight patients (83%) received nutritional support treatment, mainly using enteral combined parenteral nutrition (52.6%), followed by parenteral nutrition (37.2%), and simple enteral nutrition 10.2%. The nutritional support rate of nasopharyngeal cancer (95.4%), esophageal cancer (97.6%) and lung cancer (90.0%) was significantly higher than that of cervical cancer (38.5%) and colon cancer (37.5%), P<0.05. Conclusion: The incidence of malnutritional risk in cancer patients is relatively high, and it is increasing during radiotherapy. Nutritional support treatment ensures the completion of radiotherapy for patients. |
| 查看全文 查看/发表评论 下载PDF阅读器 |
| 关闭 |
|
|
|